EPISODE · May 7, 2020 · 8 MIN
MPR Weekly Dose Podcast Episode 33
from MPR Weekly Dose
This week we cover the the risk of antihypertensive med use during the pandemic; The Emergency Use Authorization for remdesivir in hospitalized patients with suspected or confirmed COVID-19; The addition of a Boxed Warning to Montelukast; A new Farxiga indication; And a novel treatment for acute migraines.
Embed this episode
Ready to play
MPR Weekly Dose Podcast Episode 33
0:00
8:23
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of MPR Weekly Dose?
This episode is 8 minutes long.
When was this MPR Weekly Dose episode published?
This episode was published on May 7, 2020.
Can I download this MPR Weekly Dose episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!